Insomnia treatment in the third trimester of pregnancy reduces postpartum depression symptoms: A randomized clinical trial

Psychiatry Research

Volumn 210, Issue 3, 2013, Pages 901-905

  Khazaie, Habibolah ^a   Ghadami, Mohammad Rasoul ^a   Knight, David C ^b   Emamian, Farnoosh ^a   Tahmasian, Masoud ^a,c  

^a KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Diphenhydramine; Insomnia; Postpartum depression; Sleep disorders; Trazodone

Indexed keywords

DIPHENHYDRAMINE; PLACEBO; TRAZODONE; ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DRUG EFFICACY; DRUG TOLERABILITY; EDINBURGH POSTNATAL DEPRESSION SCALE; FEMALE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; PREGNANT WOMAN; PRIORITY JOURNAL; PUERPERAL DEPRESSION; RANDOMIZED CONTROLLED TRIAL; SLEEP QUALITY; SLEEP TIME; THIRD TRIMESTER PREGNANCY; ACTIMETRY; DEPRESSION; DEPRESSION, POSTPARTUM; DRUG EFFECTS; PREGNANCY; PREGNANCY COMPLICATION; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; SLEEP; SLEEP DISORDERS; SLEEP INITIATION AND MAINTENANCE DISORDERS; TREATMENT OUTCOME;

ACTIGRAPHY; ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; DEPRESSION; DEPRESSION, POSTPARTUM; DIPHENHYDRAMINE; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, THIRD; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX; SLEEP; SLEEP DISORDERS; SLEEP INITIATION AND MAINTENANCE DISORDERS; TRAZODONE; TREATMENT OUTCOME;

EID: 84888298379     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2013.08.017     Document Type: Article

References (40)

1. Bei B., Milgrom J., Ericksen J., Trinder J. Subjective perception of sleep, but not its objective quality, is associated with immediate postpartum mood disturbances in healthy women. Sleep 2010, 33(4):531-538.
2. Bernard-Bonnin A.C. Position statement: maternal depression and child development. Paediatrics & Child Health 2004, 9(8):575-583.
3. Cox J.L., Holden J.M., Sagovsky R. Detection of postnatal depression. development of the 10-item Edinburgh Postnatal Depression Scale. British Journal of Psychiatry 1987, 150:782-786.
4. Dorheim S.K., Bondevik G.T., Eberhard-Gran M., Bjorvatn B. Subjective and objective sleep among depressed and non-depressed postnatal women. Acta Psychiatrica Scandinavica 2009, 119(2):128-136.
5. Einarson A., Bonari L., Voyer-Lavigne S., Addis A., Matsui D., Johnson Y., Koren G A multicentre prospective controlled study to determine the safety of trazodone and nefazodone use during pregnancy. Canadian Journal of Psychiatry 2003, 48(2):106-110.
6. Einarson T.R., Einarson A. Newer antidepressants in pregnancy and rates of major malformations: a meta-analysis of prospective comparative studies. Pharmacoepidemiology and Drug Safety 2005, 14(12):823-827.
7. Gavin N.I., Gaynes B.N., Lohr K.N., Meltzer-Brody S., Gartlehner G., Swinson T. Perinatal depression: a systematic review of prevalence and incidence. Obstetrics and Gynecology 2005, 106(5 Pt 1):1071-1083.
8. Gilboa S.M., Strickland M.J., Olshan A.F., Werler M.M., Correa A. Use of antihistamine medications during early pregnancy and isolated major malformations. Birth defects research. Part A. Clinical and Molecular Teratology 2009, 85(2):137-150.
9. Goyal D., Gay C., Lee K. Fragmented maternal sleep is more strongly correlated with depressive symptoms than infant temperament at three months postpartum. Archives of Women's Mental Health 2009, 12(4):229-237.
10. Grace S.L., Evindar A., Stewart D.E. The effect of postpartum depression on child cognitive development and behavior: a review and critical analysis of the literature. Archives of Women's Mental Health 2003, 6(4):263-274.
11. Khazaie H., Moradi M., Tahmasian M., Rezaei M., Dabiry S., Nikray R., Rezaie L., Younesi G., Schwebel D.C. Insomnia treatment by olanzapine. Is sleep state misperception a psychotic disorder?. Neurosciences (Riyadh) 2010, 15(2):110-112.
12. Khazaie H., Rezaie L., Tahmasian M., Schwebel D.C. An innovative new method to diagnose enuresis objectively. Neurosciences (Riyadh) 2011, 16(3):287-289.
13. Kumar A., Garg R. Possible role of trazodone and imipramine in sleep deprivation-induced anxiety-like behavior and oxidative damage in mice. Methods and Findings in Experimental and Clinical Pharmacology 2009, 31(6):383-387.
14. 2006, John Wiley & Sons. K. Lee (Ed.).
15. Lunsford-Avery J.R., Judd C.M., Axelson D.A., Miklowitz D.J. Sleep impairment, mood symptoms, and psychosocial functioning in adolescent bipolar disorder. Psychiatry Research 2012, 200(2-3):265-271.
16. Marek G.J., McDougle C.J., Price L.H., Seiden L.S. A comparison of trazodone and fluoxetine: implications for a serotonergic mechanism of antidepressant action. Psychopharmacology (Berl) 1992, 109(1-2):2-11.
17. Marques M., Bos S., Soares M.J., Maia B., Pereira A.T., Valente J., Gomes A.A., Macedo A., Azevedo M.H. Is insomnia in late pregnancy a risk factor for postpartum depression/depressive symptomatology?. Psychiatry Research 2011, 186(2-3):272-280.
18. Mashiko H., Niwa S., Kumashiro H., Kaneko Y., Suzuki S., Numata Y., Horikoshi R., Watanabe Y. Effect of trazodone in a single dose before bedtime for sleep disorders accompanied by a depressive state: dose-finding study with no concomitant use of hypnotic agent. Psychiatry and Clinical Neurosciences 1999, 53(2):193-194.
19. Meltzer-Brody S. New insights into perinatal depression: pathogenesis and treatment during pregnancy and postpartum. Dialogues in Clinical Neuroscience 2011, 13(1):89-100.
20. Montazeri A., Torkan B., Omidvari S. The Edinburgh Postnatal Depression Scale (EPDS): translation and validation study of the Iranian version. BMC Psychiatry 2007, 7:11.
21. O'hara M.W., Swain A.M. Rates and risks of postpartum depression: a meta-analysis. International Review of Psychiatry 1996, 8:37-54.
22. Odagaki Y., Toyoshima R., Yamauchi T. Trazodone and its active metabolite m-chlorophenylpiperazine as partial agonists at 5-HT1A receptors assessed by [35S]GTPgammaS binding. Journal of Psychopharmacology 2005, 19(3):235-241.
23. Okun M.L., Hanusa B.H., Hall M., Wisner J.L. Sleep complaints in late pregnancy and the recurrence of postpartum depression. Behavioral Sleep Medicine 2009, 7:106-117.
24. Okun M.L., Roberts J.M., Marsland A.L., Hall M. How disturbed sleep may be a risk factor for adverse pregnancy outcomes. Obstetrical & Gynecological Survey 2009, 64(4):273-280.
25. Okun M.L., Kiewra K., Luther J.F., Wisniewski S.R., Wisner K.L. Sleep disturbances in depressed and nondepressed pregnant women. Depression and Anxiety 2011, 28(8):676-685.
26. Pearlstein T. Perinatal depression: treatment options and dilemmas. Journal of Psychiatry & Neuroscience 2008, 33(4):302-318.
27. Posmontier B. Sleep quality in women with and without postpartum depression. Journal of Obstetric, Gynecologic, & Neonatal Nursing 2008, 37(6):722-735. (quiz 735-727).
28. Raffa R.B., Shank R.P., Vaught J.L. Etoperidone, trazodone and MCPP: in vitro and in vivo identification of serotonin 5-HT1A (antagonistic) activity. Psychopharmacology (Berl) 1992, 108(3):320-326.
29. Robertson E., Grace S., Wallington T., Stewart D.E. Antenatal risk factors for postpartum depression: a synthesis of recent literature. General Hospital Psychiatry 2004, 26(4):289-295.
30. Ross L.E., Murray B.J., Steiner M. Sleep and perinatal mood disorders: a critical review. Journal of Psychiatry & Neuroscience 2005, 30(4):247-256.
31. Roth A.J., McCall W.V., Liguori A. Cognitive, psychomotor and polysomnographic effects of trazodone in primary insomniacs. Journal of Sleep Research 2011, 20(4):552-558.
32. Roth T., Zammit G., Kushida C., Doghramji K., Mathias S.D., Wong J.M., Buysse D.J. A new questionnaire to detect sleep disorders. Sleep Medicine 2002, 3(2):99-108.
33. Sadeh A. The role and validity of actigraphy in sleep medicine: an update. Sleep Medicine Reviews 2011, 15(4):259-267.
34. Sharma S., Franco R. Sleep and its disorders in pregnancy. Wisconsin Medical Journal 2004, 103(5):48-52.
35. Studd J., Panay N. Hormones and depression in women. Climacteric 2004, 7(4):338-346.
36. Tahmasian M., Khazaie H., Sepehry A.A., Russo M.B. Ambulatory monitoring of sleep disorders. Journal of the Pakistan Medical Association 2010, 60(6):480-487.
37. Tahmasian M., Khazaie H., Golshani S., Avis K.T. Clinical application of actigraphy in psychotic disorders: a systematic review. Current Psychiatry Reports 2013, 15(6):359.
38. Unno K., Ozaki T., Mohammad S., Tsuno S., Ikeda-Sagara M., Honda K., Ikeda M. First and second generation H(1) histamine receptor antagonists produce different sleep-inducing profiles in rats. European Journal of Pharmacology 2012, 683(1-3):179-185.
39. Verbeeck R.K., Ross S.G., McKenna E.A. Excretion of trazodone in breast milk. British Journal of Clinical Pharmacology 1986, 22(3):367-370.
40. Wilkie G., Shapiro C.M. Sleep deprivation and the postnatal blues. Journal of Psychosomatic Research 1992, 36(4):309-316.